Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time.
Total raised: $10M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.10.2023 | Seed | $10M | - |
Mentions in press and media 2
| Date | Title | Description |
| 25.10.2023 | Flashpoint Therapeutics Raises $10M in Seed Funding | Flashpoint Therapeutics, a Chicago, IL-based company developing nanotechnology-enabled therapeutics for cancer and other diseases, raised $10M in Seed funding. The round was led by Beta Lab, with participation from private equity investor R... |
| 25.10.2023 | Flashpoint Therapeutics Announces $10M Seed Financing | CHICAGO, IL, Flashpoint Therapeutics announces $10M seed financing led by Beta Lab. >> Click here for more funding data on Flashpoint Therapeutics >> To export Flashpoint Therapeutics funding data to PDF and Excel, click her... |